Prof. Mondher Toumi is M.D. by training, M.Sc. in Biological Sciences and Ph.D. in Economic ciences. Mondher Toumi is Professor of Public Health at Aix-Marseille University. After working for 12 years as Research Manager in the laboratory of pharmacology at the University of Marseille, he joined the Public Health Department in 1993. He worked from 1995 in the pharmaceutical industry for 13 years. Mondher was appointed Global Vice President at Lundbeck A/S in charge of health economics, outcome research, pricing, market access, epidemiology, risk management, governmental affairs and competitive intelligence. In 2008, he founded Creativ-Ceutical, an international consulting firm dedicated to support life science industries and authorities in strategic decision-making. In February 2009 he was appointed Professor at Lyon I University in the Department of Decision Sciences and Health Policies. The same year, he was appointed Director of the Chair of Public Health and Market Access. He conducted the first European University Diploma of Market Access (EMAUD) in Paris, France. Additionally, he recently created the Market Access Society to promote research and scientific activities around market access, public health and health economic assessment. Since 2009, he also chairs the Annual Market Access Day, a purely academic event sponsored by EMAUD that has become a reference event in the area. Since September 2014, he joined the research unit EA3279 of the public health department, at Aix-Marseille University (France) as Professor. Mondher Toumi is also visiting Professor at two famous Chinese universities: Shenyang Pharmaceutical University and Beijing University (Third Hospital). In addition to contributing as a reviewer on several journals, he is Chief Editor at the online Journal of Market Access and Health Policy. He did two mandates as Co-Chair of the Research Review Committee ISPOR in 2012 and 2013. He is a recognized expert in drug development and an authority on market access and risk management. He has more than 200 scientific publications and oral communications, and has contributed to several books. He just finished a book on Market Access to become soon available.